{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T10:32:32Z","timestamp":1713349952927},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s11894-008-0040-9","type":"journal-article","created":{"date-parts":[[2008,4,26]],"date-time":"2008-04-26T11:09:58Z","timestamp":1209208198000},"page":"177-185","source":"Crossref","is-referenced-by-count":10,"title":["Endoscopy in the management of primary sclerosing cholangitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Mark","family":"McLoughlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Enns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,27]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365528709011139","volume":"22","author":"E. Aadland","year":"1987","unstructured":"Aadland E, Schrumpf E, Fausa O, et al.: Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987, 22:655\u2013664.","journal-title":"Scand J Gastroenterol"},{"key":"40_CR2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"J.M. Farrant","year":"1991","unstructured":"Farrant JM, Haller KM, Wilkinson ML, et al.: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710\u20131717.","journal-title":"Gastroenterology"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"R.H. Wiener","year":"1989","unstructured":"Wiener RH, Grabs PM, Dickson ER, et al.: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10:430\u2013436.","journal-title":"Hepatology"},{"key":"40_CR4","first-page":"685","volume":"8","author":"L. Okolicsanyi","year":"1996","unstructured":"Okolicsanyi L, Fabris L, Viaggi S, et al.: Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 1996, 8:685\u2013691.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"40_CR5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF01213311","volume":"32","author":"H. Takikawa","year":"1997","unstructured":"Takikawa H, Manabe T: Primary sclerosing cholangitis in Japan: analysis of 192 cases. J Gastroenterol 1997, 32:134\u2013137.","journal-title":"J Gastroenterol"},{"key":"40_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","volume":"11","author":"O. Fausa","year":"1991","unstructured":"Fausa O, Schrumpf E, Elgjo K: Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991, 11:31\u201339.","journal-title":"Semin Liver Dis"},{"key":"40_CR7","first-page":"503","volume":"52","author":"H.A. Shepherd","year":"1983","unstructured":"Shepherd HA, Selby WS, Chapman RW, et al.: Ulcerative colitis and persistent liver dysfunction. Q J Med 1983, 52:503\u2013513.","journal-title":"Q J Med"},{"key":"40_CR8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1040541","volume":"8","author":"E. Schrumpf","year":"1988","unstructured":"Schrumpf E, Fausa O, Elgjo K, et al.: Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis 1988, 8:201\u2013209.","journal-title":"Semin Liver Dis"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A. Bergquist","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, et al.: Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002, 36:321\u2013327.","journal-title":"J Hepatol"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.510250501","volume":"25","author":"K. Shetty","year":"1997","unstructured":"Shetty K, Rybicki L, Carey WD: The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997, 25:1049\u20131053.","journal-title":"Hepatology"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.510290607","volume":"29","author":"W.R. Kim","year":"1999","unstructured":"Kim WR, Poterucha JJ, Wiesner RH, et al.: The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999, 29:1643\u20131648.","journal-title":"Hepatology"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1089-3261(03)00127-2","volume":"8","author":"F.D. Mendes","year":"2004","unstructured":"Mendes FD, Lindor KD: Primary sclerosing cholangitis. Clin Liver Dis 2004, 8:195\u2013211.","journal-title":"Clin Liver Dis"},{"key":"40_CR13","first-page":"1136","volume":"85","author":"A.N. Langnas","year":"1990","unstructured":"Langnas AN, Grazi GL, Stratta RJ, et al.: Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol 1990, 85:1136\u20131141.","journal-title":"Am J Gastroenterol"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00054725-200501000-00009","volume":"11","author":"J.A. Talwalkar","year":"2005","unstructured":"Talwalkar JA, Lindor KD: Primary sclerosing cholangitis. Inflamm Bowel Dis 2005, 11:62\u201372.","journal-title":"Inflamm Bowel Dis"},{"key":"40_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2005.12.034","volume":"64","author":"S.L. Moff","year":"2006","unstructured":"Moff SL, Kamel IR, Eustace J, et al.: Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc 2006, 64:219\u2013223.","journal-title":"Gastrointest Endosc"},{"key":"40_CR16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","volume":"4","author":"A.E. Berstad","year":"2006","unstructured":"Berstad AE, Aabakken L, Smith HJ, et al.: Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2006, 4:514\u2013520.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"40_CR17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2214\/ajr.179.2.1790399","volume":"179","author":"K.M. Vitellas","year":"2002","unstructured":"Vitellas KM, El-Dieb A, Vaswani KK, et al.: MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography. AJR Am J Roentgenol 2002, 179:399\u2013407.","journal-title":"AJR Am J Roentgenol"},{"key":"40_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2214\/ajr.178.2.1780327","volume":"178","author":"K.M. Vitellas","year":"2002","unstructured":"Vitellas KM, Enns RA, Keogan MT, et al.: Comparison of MR cholangiopancreatographic techniques with contrastenhanced cholangiography in the evaluation of sclerosing cholangitis. AJR Am J Roentgenol 2002, 178:327\u2013334.","journal-title":"AJR Am J Roentgenol"},{"key":"40_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.20287","volume":"40","author":"J.A. Talwalkar","year":"2004","unstructured":"Talwalkar JA, Angulo P, Johnson CD, et al.: Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis. Hepatology 2004, 40:39\u201345.","journal-title":"Hepatology"},{"key":"40_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.dld.2004.03.018","volume":"36","author":"V. Macchi","year":"2004","unstructured":"Macchi V, Floreani A, Marchesi P, et al.: Imaging of primary sclerosing cholangitis: preliminary results by two new non-invasive techniques. Dig Liver Dis 2004, 36:614\u2013621.","journal-title":"Dig Liver Dis"},{"key":"40_CR21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2036.2005.02407.x","volume":"21","author":"S.N. Cullen","year":"2005","unstructured":"Cullen SN, Chapman RW: Review article: current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 2005, 21:933\u2013948.","journal-title":"Aliment Pharmacol Ther"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","volume":"98","author":"K.W. Burak","year":"2003","unstructured":"Burak KW, Angulo P, Lindor KD: Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 2003, 98:1155\u20131158.","journal-title":"Am J Gastroenterol"},{"key":"40_CR23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","volume":"35","author":"P. Angulo","year":"2002","unstructured":"Angulo P, Maor-Kendler Y, Lindor KD: Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 2002, 35:1494\u20131500.","journal-title":"Hepatology"},{"key":"40_CR24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","volume":"51","author":"E. Bjornsson","year":"2002","unstructured":"Bjornsson E, Boberg KM, Cullen S, et al.: Patients with small duct primary sclerosing cholangitis have a favourable long-term prognosis. Gut 2002, 51:731\u2013735.","journal-title":"Gut"},{"key":"40_CR25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","volume":"36","author":"U. Broome","year":"2002","unstructured":"Broome U, Glaumann H, Lindstom E, et al.: Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002, 36:586\u2013589.","journal-title":"J Hepatol"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","volume":"16","author":"U. Beuers","year":"1992","unstructured":"Beuers U, Spengler U, Kruis W, et al.: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebocontrolled trial. Hepatology 1992, 16:707\u2013714.","journal-title":"Hepatology"},{"key":"40_CR27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1590-8658(03)00076-8","volume":"35","author":"L. Okolicsanyi","year":"2003","unstructured":"Okolicsanyi L, Groppo M, Floreani A, et al.: Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis 2003, 35:325\u2013331.","journal-title":"Dig Liver Dis"},{"key":"40_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","volume":"20","author":"A. Stiehl","year":"1994","unstructured":"Stiehl A, Walker S, Stiehl L, et al.: Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 1994, 20:57\u201364.","journal-title":"J Hepatol"},{"key":"40_CR29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(98)80059-7","volume":"29","author":"H.J. Hoogstraten van","year":"1998","unstructured":"van Hoogstraten HJ, Wolfhagen FH, van de Meeberg PC, et al.: Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. J Hepatol 1998, 29:417\u2013423.","journal-title":"J Hepatol"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"K.D. Lindor","year":"1997","unstructured":"Lindor KD: Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997, 336:691\u2013695.","journal-title":"N Engl J Med"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","volume":"121","author":"S.A. Mitchell","year":"2001","unstructured":"Mitchell SA, Bansi DS, Hunt N, et al.: A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001, 121:900\u2013907.","journal-title":"Gastroenterology"},{"key":"40_CR32","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","volume":"96","author":"D.M. Harnois","year":"2001","unstructured":"Harnois DM, Angulo P, Jorgensen RA, et al.: High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001, 96:1558\u20131562.","journal-title":"Am J Gastroenterol"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R. Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, de Muckadell OS, et al.: High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005, 129:1464\u20131472.","journal-title":"Gastroenterology"},{"key":"40_CR34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","volume":"124","author":"D.S. Pardi","year":"2003","unstructured":"Pardi DS, Loftus EV, Jr, Kremers WK, et al.: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889\u2013893.","journal-title":"Gastroenterology"},{"key":"40_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","volume":"134","author":"B.Y. Tung","year":"2001","unstructured":"Tung BY, Emond MJ, Haggitt RC, et al.: Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001, 134:89\u201395.","journal-title":"Ann Intern Med"},{"key":"40_CR36","first-page":"57","volume":"86","author":"K.D. Lindor","year":"1991","unstructured":"Lindor KD, Wiesner RH, Colwell LJ, et al.: The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991, 86:57\u201361.","journal-title":"Am J Gastroenterol"},{"key":"40_CR37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-131-12-199912210-00006","volume":"131","author":"C. Schramm","year":"1999","unstructured":"Schramm C, Schirmacher P, Helmreich-Becker I, et al.: Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Ann Intern Med 1999, 131:943\u2013946.","journal-title":"Ann Intern Med"},{"key":"40_CR38","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0002-9270(00)01059-5","volume":"95","author":"H.J. Hoogstraten van","year":"2000","unstructured":"van Hoogstraten HJ, Vleggaar FP, Boland GJ, et al.: Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am J Gastroenterol 2000, 95:2015\u20132022.","journal-title":"Am J Gastroenterol"},{"key":"40_CR39","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1572-0241.2002.05869.x","volume":"97","author":"R. Kita","year":"2002","unstructured":"Kita R, Kita-Sasai Y, Hanaoka I, et al.: Beneficial effect of bezafibrate on primary sclerosing cholangitis (three case reports). Am J Gastroenterol 2002, 97:1849\u20131851.","journal-title":"Am J Gastroenterol"},{"key":"40_CR40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","volume":"106","author":"T.A. Knox","year":"1994","unstructured":"Knox TA, Kaplan MM: A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994, 106:494\u2013499.","journal-title":"Gastroenterology"},{"key":"40_CR41","first-page":"455","volume":"90","author":"D.H. Thiel Van","year":"1995","unstructured":"Van Thiel DH, Carroll P, Abu-Elmagd K, et al.: Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995, 90:455\u2013459.","journal-title":"Am J Gastroenterol"},{"key":"40_CR42","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","volume":"95","author":"A.E. Bharucha","year":"2000","unstructured":"Bharucha AE, Jorgensen R, Lichtman SN, et al.: A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000, 95:2338\u20132342.","journal-title":"Am J Gastroenterol"},{"key":"40_CR43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-200012000-00005","volume":"31","author":"A. Duchini","year":"2000","unstructured":"Duchini A, Younossi ZM, Saven A, et al.: An open-label pilot trial of cladribrine (2-chlorodeoxyadenosine) in patients with primary sclerosing cholangitis. J Clin Gastroenterol 2000, 31:292\u2013296.","journal-title":"J Clin Gastroenterol"},{"key":"40_CR44","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1001\/jama.1992.03490230089034","volume":"268","author":"E.A. Jones","year":"1992","unstructured":"Jones EA, Bergasa NV: The pruritus of cholestasis and the opioid system. JAMA 1992, 268:3359\u20133362.","journal-title":"JAMA"},{"key":"40_CR45","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0168-8278(03)00006-0","volume":"38Suppl1","author":"C. Levy","year":"2003","unstructured":"Levy C, Lindor KD: Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2003, 38(Suppl 1):S24\u2013S37.","journal-title":"J Hepatol"},{"key":"40_CR46","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","volume":"95","author":"C.H. Janes","year":"1995","unstructured":"Janes CH, Dickson ER, Okazaki R, et al.: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995, 95:2581\u20132586.","journal-title":"J Clin Invest"},{"key":"40_CR47","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","volume":"96","author":"M. Kaya","year":"2001","unstructured":"Kaya M, Petersen BT, Angulo P, et al.: Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 2001, 96:1059\u20131066.","journal-title":"Am J Gastroenterol"},{"key":"40_CR48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","volume":"37","author":"G.K. Johnson","year":"1991","unstructured":"Johnson GK, Geenen JE, Venu RP, et al.: Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. Gastrointest Endosc 1991, 37:38\u201343.","journal-title":"Gastrointest Endosc"},{"key":"40_CR49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-2008-1040421","volume":"11","author":"P.B. Cotton","year":"1991","unstructured":"Cotton PB, Nickl N: Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis. Semin Liver Dis 1991, 11:40\u201348.","journal-title":"Semin Liver Dis"},{"key":"40_CR50","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/gut.32.11.1364","volume":"32","author":"M. Lombard","year":"1991","unstructured":"Lombard M, Farrant M, Karani J, et al.: Improving biliaryenteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Gut 1991, 32:1364\u20131368.","journal-title":"Gut"},{"key":"40_CR51","first-page":"2000","volume":"88","author":"A.A. Gaing","year":"1993","unstructured":"Gaing AA, Geders JM, Cohen SA, et al.: Endoscopic management of primary sclerosing cholangitis: review and report of an open series. Am J Gastroenterol 1993, 88:2000\u20132008.","journal-title":"Am J Gastroenterol"},{"key":"40_CR52","first-page":"661","volume":"21","author":"J.G. Lee","year":"1995","unstructured":"Lee JG, Schutz SM, England RE, et al.: Endoscopic therapy of sclerosing cholangitis. Hepatology 1995, 21:661\u2013667.","journal-title":"Hepatology"},{"key":"40_CR53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-2007-1005675","volume":"27","author":"J.L. Laethem Van","year":"1995","unstructured":"Van Laethem JL, Deviere J, Bourgeois N, et al.: Cholangiographic findings in deteriorating primary sclerosing cholangitis. Endoscopy 1995, 27:223\u2013228.","journal-title":"Endoscopy"},{"key":"40_CR54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0016-5107(96)70167-0","volume":"44","author":"A.W. Milligen de Wit van","year":"1996","unstructured":"van Milligen de Wit AW, van Bracht J, Rauws EA, et al.: Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1996, 44:293\u2013299.","journal-title":"Gastrointest Endosc"},{"key":"40_CR55","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2007-1005552","volume":"28","author":"S. Wagner","year":"1996","unstructured":"Wagner S, Gebel M, Meier P, et al.: Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 1996, 28:546\u2013551.","journal-title":"Endoscopy"},{"key":"40_CR56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00000658-199803000-00014","volume":"227","author":"S.A. Ahrendt","year":"1998","unstructured":"Ahrendt SA, Pitt HA, Kalloo AN, et al.: Primary sclerosing cholangitis: resect, dilate, or transplant? Ann Surg 1998, 227:412\u2013423.","journal-title":"Ann Surg"},{"key":"40_CR57","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/j.1572-0241.1999.01364.x","volume":"94","author":"C.Y. Ponsioen","year":"1999","unstructured":"Ponsioen CY, Lam K, van Milligen de Wit AW, et al.: Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999, 94:2403\u20132407.","journal-title":"Am J Gastroenterol"},{"key":"40_CR58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","volume":"53","author":"A.R. Baluyut","year":"2001","unstructured":"Baluyut AR, Sherman S, Lehman GA, et al.: Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001, 53:308\u2013312.","journal-title":"Gastrointest Endosc"},{"key":"40_CR59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","volume":"36","author":"A. Stiehl","year":"2002","unstructured":"Stiehl A, Rudolph G, Kloters-Plachky P, et al.: Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002, 36:151\u2013156.","journal-title":"J Hepatol"},{"key":"40_CR60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11894-006-0011-y","volume":"8","author":"G.K. Johnson","year":"2006","unstructured":"Johnson GK, Saeian K, Geenen JE: Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation. Curr Gastroenterol Rep 2006, 8:147\u2013155.","journal-title":"Curr Gastroenterol Rep"},{"key":"40_CR61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1155\/2003\/475603","volume":"17","author":"R. Enns","year":"2003","unstructured":"Enns R, Eloubeidi MA, Mergener K, et al.: Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. Can J Gastroenterol 2003, 17:243\u2013248.","journal-title":"Can J Gastroenterol"},{"key":"40_CR62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","volume":"102","author":"A. Andriulli","year":"2007","unstructured":"Andriulli A, Loperfido S, Napolitano G, et al.: Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007, 102:1781\u20131788.","journal-title":"Am J Gastroenterol"},{"key":"40_CR63","first-page":"2235","volume":"94","author":"F.H. Al-Kawas","year":"1999","unstructured":"Al-Kawas FH: Endoscopic management of primary sclerosing cholangitis: less is better! Am J Gastroenterol 1999, 94:2235\u20132236.","journal-title":"Am J Gastroenterol"},{"key":"40_CR64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11894-006-0067-8","volume":"8","author":"P. Charatcharoenwitthaya","year":"2006","unstructured":"Charatcharoenwitthaya P, Lindor KD: Primary sclerosing cholangitis: diagnosis and management. Curr Gastroenterol Rep 2006, 8:75\u201382.","journal-title":"Curr Gastroenterol Rep"},{"key":"40_CR65","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","volume":"50","author":"C. Levy","year":"2005","unstructured":"Levy C, Lymp J, Angulo P, et al.: The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005, 50:1734\u20131740.","journal-title":"Dig Dis Sci"},{"key":"40_CR66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","volume":"56","author":"E. Siqueira","year":"2002","unstructured":"Siqueira E, Schoen RE, Silverman W, et al.: Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002, 56:40\u201347.","journal-title":"Gastrointest Endosc"},{"key":"40_CR67","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-2002-35298","volume":"34","author":"B. Lindberg","year":"2002","unstructured":"Lindberg B, Arnelo U, Bergquist A, et al.: Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 2002, 34:909\u2013916.","journal-title":"Endoscopy"},{"key":"40_CR68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00261-007-9314-1","volume":"33","author":"S.L. Walker","year":"2008","unstructured":"Walker SL, McCormick PA: Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an \u201cevidence based radiology\u201d review. Abdom Imaging 2008, 33:14\u201317.","journal-title":"Abdom Imaging"},{"key":"40_CR69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.20469","volume":"101","author":"J. Koopmann","year":"2004","unstructured":"Koopmann J, Thuluvath PJ, Zahurak ML, et al.: Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 2004, 101:1609\u20131615.","journal-title":"Cancer"},{"key":"40_CR70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2004-828894","volume":"24","author":"F. Berr","year":"2004","unstructured":"Berr F: Photodynamic therapy for cholangiocarcinoma. Semin Liver Dis 2004, 24:177\u2013187.","journal-title":"Semin Liver Dis"},{"key":"40_CR71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5107(04)01288-X","volume":"60","author":"M. Wiedmann","year":"2004","unstructured":"Wiedmann M, Berr F, Schiefke I, et al.: Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc 2004, 60:68\u201375.","journal-title":"Gastrointest Endosc"},{"key":"40_CR72","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.transproceed.2003.09.017","volume":"35","author":"E. Solano","year":"2003","unstructured":"Solano E, Khakhar A, Bloch M, et al.: Liver transplantation for primary sclerosing cholangitis. Transplant Proc 2003, 35:2431\u20132434.","journal-title":"Transplant Proc"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-008-0040-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0040-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:04:02Z","timestamp":1559433842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-008-0040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s11894-008-0040-9","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}